Chloe Kent
Reporter
Chloe is an award-winning journalist who has specialized in health reporting throughout her career, with a particular focus on women's health and access to medicine. Before joining Generics Bulletin she worked for B2B publishing consortium Verdict, writing about medical technology and pharmaceuticals. Having graduated from the University of York, she went on to train as a journalist with the Press Association.
Latest From Chloe Kent
US Patients Continue To Overpay For Off-Patent Drugs Despite $373bn In Savings
The US Association for Accessible Medicines’ annual report into generic and biosimilar savings has documented another year of increased cost savings thanks to off-patent drugs, but says some patients are still overpaying for their generic medicines.
EMA And HMA Speak Out In Favor Of Biosimilar Interchangeability
Stakeholders in Europe have been hesitant to allow interchangeable substitution of biological products, prompting the European Medicines Agency to clarify its stance on the issue.
MPP Teams Up With MedinCell For Investigational Malaria Transmission Treatment
The Medicines Patent Pool has secured a licensing deal with MedinCell for a long-acting injectable ivermectin drug formulation which could be used to prevent ongoing spread of malaria.
Earnings Recovery For Nichi-Iko Unlikely Before Full Resumption Of Toyama Shipments
Nichi-Iko still has a long road to recovery ahead as it attempts to get its Toyama plant back on its feet.
US Patients Increasingly Reliant On Pharmacy Discount Cards For Generics
IQVIA has published a white paper examining the growing reliance on pharmacy discount cards to pay for prescriptions in the US.
All About Unlocking Eve: The Initiative Advancing Women In Healthcare Leadership
In Vivo's Chloe Kent discussed the future of women in healthcare leadership with Roche executives and Unlocking Eve founders Eva McLellan and Kaye Vitug.